Disc Medicine, Inc. (IRON)
69.77
+1.65
(+2.42%)
USD |
NASDAQ |
May 27, 16:00
69.77
0.00 (0.00%)
After-Hours: 18:43
Disc Medicine Cash from Investing (Quarterly) : 58.31M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | -428.90M |
| REGENXBIO, Inc. | 70.59M |
| Replimune Group, Inc. | 75.12M |
| Olema Pharmaceuticals, Inc. | 4.529M |
| Moderna, Inc. | -76.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -62.24M |
| Cash from Financing (Quarterly) | 1.697M |
| Free Cash Flow | -201.34M |
| Free Cash Flow Per Share (Quarterly) | -1.617 |
| Free Cash Flow to Equity (Quarterly) | -62.27M |
| Free Cash Flow to Firm (Quarterly) | -61.39M |
| Free Cash Flow Yield | -7.90% |